2026-09930
Details
The document's own metadata, straight from the source system.
- Title
- 2026-09930
- Posted
- May 18, 2026
- Comment period
- May 18, 2026 – Jul 18, 2026
- FR Doc
- 2026-09930
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type.
Comments over time
Weekly arrivals, stacked by stance.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- Jul 17, 2026Anonymous AnonymousOpposeIndividual
The commenter opposes the proposed action on the grounds that peyote is a sacred medicine for First Nations and should be protected from corporate exploitation and pharmaceutical synthesis. They argue that the plant should remain a religious sacrament rather than a source of economic profit.
Read comment → - Jul 17, 2026Anonymous AnonymousOpposeIndividualRead comment →
- Jul 16, 2026Valentina ValdezOpposeIndividual
The commenter opposes the permit, arguing that the requested "bulk" manufacturing of substances like cocaine, LSD, ibogaine, and mescaline poses significant safety risks and threatens the cultural authority of Indigenous groups over traditional medicines. They request that the permit be denied due to the potential for abuse and the negative consequences of government-sanctioned production of these compounds.
Read comment → - Jul 16, 2026Beverly ThomasOpposeIndividualRead comment →
- Jul 16, 2026Beverly ThomasOpposeIndividualRead comment →
- Jul 15, 2026Anthony HardyOpposeIndividual
An individual is opposing the proposed action, arguing that peyote and its mescaline content are sacred medicines belonging exclusively to indigenous tribes. The commenter urges the agency to leave the mescaline alone and prevent pharmaceutical companies from monetizing it, emphasizing its role in tribal healing and cultural preservation.
Read comment → - Jul 15, 2026Anonymous AnonymousOpposeIndividualRead comment →
